Omega-3 Fatty Acids (EPA/DHA)Omega-3 Fatty Acids (EPA/DHA)
fatty_acid
别名: Fish Oil, Marine Omega-3, Eicosapentaenoic Acid, Docosahexaenoic Acid, EPA, DHA
About
Omega-3 fatty acids, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are long-chain polyunsaturated fats from marine sources that support cardiovascular health through multiple mechanisms. EPA/DHA incorporate into cell membranes, modulate inflammatory signaling, lower plasma triglycerides, and improve endothelial function. The REDUCE-IT trial demonstrated that high-dose EPA (4g/day) reduced major adverse cardiovascular events by 25%.
How It Works
Long-chain polyunsaturated fatty acids that incorporate into cell membranes modulating inflammatory signaling via reduced arachidonic acid conversion to pro-inflammatory eicosanoids; lower plasma triglycerides by reducing hepatic VLDL production and increasing lipoprotein lipase activity; improve endothelial function by enhancing nitric oxide bioavailability; stabilize cardiac myocyte membranes reducing arrhythmia susceptibility through ion channel modulation.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| High Triglycerides (Hypertriglyceridemia) | A | 50 | 20000 | 查看 → |
| Coronary Artery Disease (CAD) | B | 20 | 50000 | 查看 → |
| Cardiac Arrhythmia | B | 15 | 10000 | 查看 → |
Side Effects
- Fishy aftertaste or burping
- Mild gastrointestinal discomfort
- Potential increased bleeding time at very high doses
- May increase atrial fibrillation risk at doses >2g/day
Drug & Supplement Interactions
- Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- Blood pressure medications (additive hypotensive effect)
- Orlistat (may reduce omega-3 absorption)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。